TY - JOUR
T1 - Agonist-Specific Regulation of G Protein-Coupled Receptors after Chronic Opioid Treatment
AU - Adhikary, Sweta
AU - Koita, Omar
AU - Lebowitz, Joseph J.
AU - Birdsong, William T.
AU - Williams, John T.
N1 - Funding Information:
This work was supported by National Institutes of Health National Institute on Drug Abuse [Grant R01-DA004523] and [Grant T32-DA007262] (to J.T.W.) and Achievement Rewards for College Scientist (to S.A.). No author has an actual or perceived conflict of interest. dx.doi.org/10.1124/molpharm.121.000453.
Publisher Copyright:
© 2022 by The American Society for Pharmacology and Experimental Therapeutics.
PY - 2022/5/1
Y1 - 2022/5/1
N2 - Chronic treatment of animals with morphine results in a long lasting cellular tolerance in the locus coeruleus and alters the kinase dependent desensitization of opioid and nonopioid G protein- coupled receptors (GPCRs). This study examined the development of tolerance and altered regulation of kinase activity after chronic treatment of animals with clinically relevant opioids that differ in efficacy at the m-opioid receptors (MOR). In slices from oxycodone treated animals, no tolerance to opioids was observed when measuring theMOR induced increase in potassium conductance, but the G protein receptor kinase 2/3 blocker, compound 101, no longer inhibited desensitization of somatostatin (SST) receptors. Chronic fentanyl treatment induced a rightward shift in the concentration response to [Met5]enkephalin, but there was no change in the kinase regulation of desensitization of the SST receptor. When total phosphorylation deficientMORs that block desensitization, internalization, and tolerance were virally expressed, chronic treatment with fentanyl resulted in the altered kinase regulation of SST receptors. The results suggest that sustained opioid receptor signaling initiates the process that results in altered kinase regulation of not only opioid receptors, but also other GPCRs. This study highlights two very distinct downstream adaptive processes that are specifically regulated by an agonist dependent mechanism.
AB - Chronic treatment of animals with morphine results in a long lasting cellular tolerance in the locus coeruleus and alters the kinase dependent desensitization of opioid and nonopioid G protein- coupled receptors (GPCRs). This study examined the development of tolerance and altered regulation of kinase activity after chronic treatment of animals with clinically relevant opioids that differ in efficacy at the m-opioid receptors (MOR). In slices from oxycodone treated animals, no tolerance to opioids was observed when measuring theMOR induced increase in potassium conductance, but the G protein receptor kinase 2/3 blocker, compound 101, no longer inhibited desensitization of somatostatin (SST) receptors. Chronic fentanyl treatment induced a rightward shift in the concentration response to [Met5]enkephalin, but there was no change in the kinase regulation of desensitization of the SST receptor. When total phosphorylation deficientMORs that block desensitization, internalization, and tolerance were virally expressed, chronic treatment with fentanyl resulted in the altered kinase regulation of SST receptors. The results suggest that sustained opioid receptor signaling initiates the process that results in altered kinase regulation of not only opioid receptors, but also other GPCRs. This study highlights two very distinct downstream adaptive processes that are specifically regulated by an agonist dependent mechanism.
UR - http://www.scopus.com/inward/record.url?scp=85128246345&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128246345&partnerID=8YFLogxK
U2 - 10.1124/molpharm.121.000453
DO - 10.1124/molpharm.121.000453
M3 - Article
C2 - 35193934
AN - SCOPUS:85128246345
SN - 0026-895X
VL - 101
SP - 300
EP - 308
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 5
ER -